Ariola, Sara Jane .
HRN: 09-51-58 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/11/2024
CEFUROXIME 1.5GM (VIAL)
10/11/2024
10/18/2024
IV
900 MG
EVERY 8 HOURS
PCAP-C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes